EKBAX
Price
$19.92
Change
-$0.36 (-1.78%)
Updated
Jul 2 closing price
Net Assets
2.49B
RIDBX
Price
$27.14
Change
+$0.31 (+1.16%)
Updated
Jul 2 closing price
Net Assets
146.86B
Interact to see
Advertisement

EKBAX vs RIDBX

EKBAX vs RIDBX Comparison Chart in %
View a ticker or compare two or three
VS
EKBAX vs. RIDBX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKBAX is a Hold and RIDBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIDBX has more cash in the bank: 147B vs. EKBAX (2.49B). RIDBX pays higher dividends than EKBAX: RIDBX (2.81) vs EKBAX (0.40). EKBAX was incepted earlier than RIDBX: EKBAX (28 years) vs RIDBX (24 years). RIDBX (1.35) is less costly to investors than EKBAX (1.08). RIDBX is a more actively managed with annual turnover of: 65.00 vs. EKBAX (20.00). RIDBX has a lower initial minimum investment than EKBAX: RIDBX (250) vs EKBAX (1000). EKBAX annual gain was more profitable for investors over the last year : 37.66 vs. RIDBX (6.03). EKBAX return over 5 years is better than : 60.60 vs. RIDBX (19.43).
EKBAXRIDBXEKBAX / RIDBX
Total Expense Ratio1.081.3580%
Annual Report Gross Expense Ratio1.081.3580%
Fund Existence28 years24 years-
Gain YTD31.8356.740472%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.49B147B2%
Annual Yield % from dividends0.402.8114%
Returns for 1 year37.666.03624%
Returns for 3 years77.5032.17241%
Returns for 5 years60.6019.43312%
Returns for 10 years132.4750.52262%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VDIGX32.030.39
+1.23%
Vanguard Dividend Growth Inv
JEUIX19.590.13
+0.67%
Janus Henderson Global Sust Eq I
LMCRX37.570.04
+0.11%
Lord Abbett Mid Cap Stock R3
GERCX13.62-0.29
-2.08%
Goldman Sachs Em Mkts Eq Insghts C
RYMCX11.02-0.36
-3.16%
Royce Micro-Cap Consult